Concurrent hepatic cirrhosis and chronic lymphocytic leukemia: a challenging coexistence: a case report

Area of Science:

• Hematology
• Hepatology
• Oncology

Background:

• Chronic lymphocytic leukemia (CLL) is a B-cell malignancy common in the elderly, presenting with lymphocytosis, lymphadenopathy, and cytopenia.
• Hepatic cirrhosis, characterized by liver fibrosis and portal hypertension, shares clinical features with CLL, such as splenomegaly and cytopenia, complicating diagnosis.
• Concurrent CLL and hepatic cirrhosis present significant diagnostic and management challenges due to overlapping clinical manifestations.

Purpose of the Study:

• To highlight the diagnostic complexities of co-occurring chronic lymphocytic leukemia and hepatic cirrhosis.
• To emphasize the need for a multidisciplinary approach in managing such complex cases.
• To underscore the importance of individualized treatment strategies for optimizing patient outcomes.

Main Methods:

• Presentation of an 84-year-old Iranian male patient with established hepatic cirrhosis.
• Initial evaluation included assessment of abdominal pain, massive splenomegaly, lymphocytosis, anemia, and cachexia.
• Diagnostic confirmation involved lymphocyte-dominant leukocytosis analysis, smudge cells, immunophenotyping for CLL (CD5+, CD19+, CD20+, CD23+), and imaging for liver cirrhosis, portal hypertension, and esophageal varices.

Main Results:

• The patient presented with clinical features suggestive of both hepatic cirrhosis and chronic lymphocytic leukemia.
• Immunophenotyping confirmed the diagnosis of chronic lymphocytic leukemia.
• Imaging revealed co-existing liver cirrhosis, portal hypertension, and esophageal varices.

Conclusions:

• Concurrent chronic lymphocytic leukemia and hepatic cirrhosis present significant diagnostic challenges.
• A multidisciplinary approach and targeted diagnostic strategies are crucial for differentiating overlapping clinical features.
• Individualized treatment is essential for optimizing outcomes and quality of life in patients with both conditions.